MindWalk Holdings HYFT
NASDAQ HYFT
$1.29 -0.06 (-4.44%)
At close: Sep 9, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026)

MindWalk Holdings' (HYFT) quarterly Cash & Equivalents came in at $8.3 million in Q2 2026, up 10.46% year-over-year from $7.5 million in Q2 2025, and down 18.36% quarter-over-quarter from $10.1 million in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Cash & Equivalents for 7 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Equivalents rose 10.46% year-over-year to $8.3 million in Q2 2026; TTM through Apr 2026 was $8.3 million, a 10.46% increase from a year earlier, with the FY2026 full-year figure at $8.2 million, up 7.42% from the prior year.
  • Cash & Equivalents was $8.3 million for Q2 2026 at MindWalk Holdings, down from $10.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $26.1 million in Q1 2022 and troughed at $2.6 million in Q2 2024.
  • A 5-year average of $9.1 million and a median of $7.9 million in 2025 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents sank 73.94% in 2023 and soared 348.79% in 2025, its largest moves.
  • Over 5 years, Cash & Equivalents stood at $11.3 million in 2022, then tumbled by 60.3% to $4.5 million in 2023, then plunged by 41.1% to $2.7 million in 2024, then jumped by 348.79% to $11.9 million in 2025, then slumped by 30.43% to $8.3 million in 2026.
  • The last three Cash & Equivalents figures came in at $8.3 million (Q2 2026), $10.1 million (Q1 2026), and $11.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 1.91 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 502.69 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 192.03 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 928.39 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 168.60 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - 404.92 Mn
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 84.54 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 8.28 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn - 1.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 8.28 Mn
Jan 31, 2026 10.14 Mn
Oct 31, 2025 11.90 Mn
Jul 31, 2025 3.56 Mn
Apr 30, 2025 7.49 Mn
Jan 31, 2025 9.16 Mn
Oct 31, 2024 2.65 Mn
Jul 31, 2024 2.92 Mn
Apr 30, 2024 2.61 Mn
Jan 31, 2024 4.65 Mn
Oct 31, 2023 4.50 Mn
Jul 31, 2023 5.10 Mn
Apr 30, 2023 6.18 Mn
Jan 31, 2023 8.46 Mn
Oct 31, 2022 11.34 Mn
Jul 31, 2022 14.96 Mn
Apr 30, 2022 23.72 Mn
Jan 31, 2022 26.06 Mn
Oct 31, 2021 30.51 Mn
Jul 31, 2021 33.13 Mn